American Century Companies Inc Eq Rx, Inc. Transaction History

American Century Companies Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$1.66 - $2.31 $102,348 - $142,425	61,656 Added 35.14%	237,120 $526,000
Q2 2023 Aug 14, 2023	BUY	$1.61 - $1.96 $102,304 - $124,544	63,543 Added 56.77%	175,464 $326,000
Q1 2023 May 11, 2023	BUY	$1.8 - $2.83 $32,592 - $51,242	18,107 Added 19.3%	111,921 $217,000
Q4 2022 Feb 13, 2023	BUY	$2.05 - $5.5 $72,034 - $193,264	35,139 Added 59.89%	93,814 $230,000
Q3 2022 Nov 14, 2022	BUY	$0.94 - $5.99 $28,717 - $183,000	30,551 Added 108.63%	58,675 $290,000
Q2 2022 Aug 12, 2022	BUY	$3.2 - $5.69 $89,996 - $160,025	28,124 New	28,124 $132,000

67.8M

Ticker EQRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 448,140,992
Description
EQRx, Inc., a pharmaceutical company, engages in developing medicines primarily for the treatment of oncology and immune-inflammatory diseases in the United States. The company's pre-registrational programs in Phase III clinical trial include Aumolertinib, an epidermal growth factor receptor (EGFR) inhibitor for the treatment of patients with EG...

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

Stay updated on American Century Companies Inc with notifications on news.